Apexigen Inc. (APGN)
Apexigen Statistics
Share Statistics
Apexigen has 24.86M shares outstanding. The number of shares has increased by 0% in one year.
| 24.86M |
| 0% |
| 0% |
| n/a |
| n/a |
| 189 |
| 0.07% |
Short Selling Information
The latest short interest is 107.25K, so 0.43% of the outstanding shares have been sold short.
| 107.25K |
| 0.43% |
| 0.45% |
| 3.8 |
Valuation Ratios
The PE ratio is -0.43 and the forward PE ratio is null. Apexigen's PEG ratio is -0.01.
| -0.43 |
| n/a |
| 0 |
| n/a |
| 2.12 |
| -0.44 |
| -0.01 |
Enterprise Valuation
Apexigen has an Enterprise Value (EV) of -1.2M.
| 0 |
| 0.04 |
| 0.04 |
| 0.04 |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.02.
| 1.29 |
| 1.29 |
| 0.02 |
| n/a |
| n/a |
| 52.98 |
Financial Efficiency
Return on Equity is -493.21% and Return on Invested Capital is -494.48%.
| -493.21% |
| -137.62% |
| -494.48% |
| n/a |
| $-2,859,272.73 |
| 11 |
| 0 |
| n/a |
Taxes
| -617K |
| 1.92% |
Stock Price Statistics
The stock price has increased by 1.3% in the last 52 weeks. The beta is 3.62, so Apexigen's price volatility has been higher than the market average.
| 3.62 |
| 1.3% |
| 0.42 |
| 0.83 |
| 44.28 |
| 262,332 |
Balance Sheet
The company has 14.8M in cash and 106K in debt, giving a net cash position of 14.7M.
| 14.8M |
| 106K |
| 14.7M |
| -176.79M |
| 13.08M |
| -2.81M |
Cash Flow
In the last 12 months, operating cash flow was -30.69M and capital expenditures -57K, giving a free cash flow of -30.75M.
| -30.69M |
| -57K |
| -30.75M |
| -1.55 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
APGN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| -233.07% |
| -227.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -27.16 |
| 3 |